Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial

Journal Article · · Journal of Clinical Investigation
DOI:https://doi.org/10.1172/jci150823· OSTI ID:1879385
 [1];  [1];  [1];  [2];  [3];  [3];  [3];  [4];  [5];  [5];  [6];  [7];  [7];  [8];  [2];  [1];  [1]
  1. Univ. of Oxford (United Kingdom)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  3. Cardiff Univ., Wales (United Kingdom)
  4. Bill & Melinda Gates Medical Research Institute, Cambridge, MA (United States); Fred Hutchinson Cancer Research Center, Seattle, WA (United States)
  5. Fred Hutchinson Cancer Research Center, Seattle, WA (United States)
  6. Fred Hutchinson Cancer Research Center, Seattle, WA (United States); Univ. of Washington, Seattle, WA (United States)
  7. Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States)
  8. Duke Univ., Durham, NC (United States)

Naive and memory CD4+ T cells reactive with human immunodeficiency virus type 1 (HIV-1) are detectable in unexposed, unimmunized individuals. The contribution of preexisting CD4+ T cells to a primary immune response was investigated in 20 HIV-1–seronegative volunteers vaccinated with an HIV-1 envelope (Env) plasmid DNA prime and recombinant modified vaccinia virus Ankara (MVA) boost in the HVTN 106 vaccine trial (clinicaltrials.gov NCT02296541). Prevaccination naive or memory CD4+ T cell responses directed against peptide epitopes in Env were identified in 14 individuals. After priming with DNA, 40% (8/20) of the elicited responses matched epitopes detected in the corresponding preimmunization memory repertoires, and clonotypes were shared before and after vaccination in 2 representative volunteers. In contrast, there were no shared epitope specificities between the preimmunization memory compartment and responses detected after boosting with recombinant MVA expressing a heterologous Env. Preexisting memory CD4+ T cells therefore shape the early immune response to vaccination with a previously unencountered HIV-1 antigen.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH); Medical Research Council; Wellcome Trust
Grant/Contract Number:
89233218CNA000001
OSTI ID:
1879385
Report Number(s):
LA-UR-21-28624
Journal Information:
Journal of Clinical Investigation, Journal Name: Journal of Clinical Investigation Journal Issue: 23 Vol. 131; ISSN 0021-9738; ISSN 1558-8238
Publisher:
American Society for Clinical InvestigationCopyright Statement
Country of Publication:
United States
Language:
English

References (25)

A very high level of crossreactivity is an essential feature of the T-cell receptor journal September 1998
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses journal January 2000
Deconstructing the Peptide-MHC Specificity of T Cell Recognition journal May 2014
Determinants of immunodominance for CD4 T cells journal June 2015
Virus-Specific CD4+ Memory-Phenotype T Cells Are Abundant in Unexposed Adults journal February 2013
Some quantitative aspects of T-cell repertoire selection: the requirement for regulatory T cells: Quantitative aspects of T-cell repertoire selection journal August 2001
The many important facets of T-cell repertoire diversity journal February 2004
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses journal April 2021
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys journal July 2008
A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides journal November 2011
Disquisitions on Original Antigenic sin journal September 1966
Evolution of Antigen-specific T Cell Receptors In Vivo: Preimmune and Antigen-driven Selection of Preferred Complementarity-determining Region 3 (CDR3) Motifs journal June 1999
Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells journal June 2009
Proteome-wide analysis of HIV-specific naive and memory CD4+ T cells in unexposed blood donors journal June 2014
Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1 env/rev DNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines journal February 2000
T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev journal January 2002
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans journal April 2004
Antiviral memory phenotype T cells in unexposed adults journal August 2013
Diversity Considerations in HIV-1 Vaccine Selection journal June 2002
Antigen-Specific Development of Primary and Memory T Cells in Vivo journal April 1995
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans journal August 2020
Differences in HIV-Specific T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative Individuals journal January 2011
Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides journal April 2004
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes journal May 2006
Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells journal August 2003

Similar Records

Proteome-wide analysis of HIV-specific naive and memory CD4+ T cells in unexposed blood donors
Journal Article · Mon Jun 23 00:00:00 EDT 2014 · Journal of Experimental Medicine · OSTI ID:1625198

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Journal Article · Tue Feb 14 23:00:00 EST 2023 · Journal of Clinical Investigation · OSTI ID:2470542

Expanded breadth of the T-cell response to mosaic HIV-1 envelope DNA vaccination
Journal Article · Wed Dec 31 23:00:00 EST 2008 · Journal of Virology · OSTI ID:956488